Fei Yuan Selected Research

Stroke (Strokes)

1/2022	Comparison of carotid atherosclerotic plaque characteristics between symptomatic patients with transient ischemic attack and stroke using high-resolution magnetic resonance imaging.
1/2021	Design and validation of a recognition instrument-the stroke aid for emergency scale-to predict large vessel occlusion stroke.
1/2020	Long-term outcomes of staged recanalization for concurrent chronic total occlusion in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
10/2019	Outcomes Among Clopidogrel, Prasugrel, and Ticagrelor in ST-Elevation Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention From the TOTAL Trial.
1/2019	Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial.
1/2017	Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial.
1/2017	Relation of Low-Density Lipoprotein Cholesterol to Ischemic Stroke in Patients With Nonvalvular Atrial Fibrillation.
4/2016	Very Long-term Outcomes and Predictors of Percutaneous Coronary Intervention with Drug-eluting Stents Versus Coronary Artery Bypass Grafting for Patients with Unprotected Left Main Coronary Artery Disease.
11/2015	Radial versus femoral access for elderly patients with acute coronary syndrome undergoing coronary angiography and intervention: insights from the RIVAL trial.
5/2015	[Long-term outcomes of patients with unprotected left main coronary artery disease post revascularization].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fei Yuan Research Topics

Disease

48	Neoplasms (Cancer) 12/2021 - 04/2004
26	Stomach Neoplasms (Stomach Cancer) 02/2022 - 04/2005
14	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 07/2012
13	Myocardial Infarction 04/2020 - 02/2008
11	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2009
11	Thrombosis (Thrombus) 01/2020 - 03/2006
10	Hemorrhage 01/2022 - 03/2006
10	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 02/2008
10	Stroke (Strokes) 01/2022 - 05/2015
9	ST Elevation Myocardial Infarction 01/2020 - 01/2014
7	Death (Near-Death Experience) 01/2020 - 01/2014
7	Hypoxia (Hypoxemia) 01/2016 - 10/2007
6	Choroidal Neovascularization 08/2022 - 12/2014
6	Lung Neoplasms (Lung Cancer) 12/2021 - 01/2014
6	Infections 07/2021 - 05/2008
6	Glioma (Gliomas) 06/2020 - 03/2014
5	Fibrosis (Cirrhosis) 08/2022 - 10/2018
5	Hypertension (High Blood Pressure) 08/2021 - 01/2011
5	Lymphatic Metastasis 01/2021 - 07/2005
5	Atrial Fibrillation 01/2021 - 03/2015
5	Infarction (Infarctions) 01/2020 - 01/2008
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2015 - 02/2010
4	Inflammation (Inflammations) 08/2022 - 01/2013
4	Dyslipidemias (Dyslipidemia) 01/2021 - 01/2008
3	Burns 01/2022 - 01/2014
3	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 09/2013
3	Pain (Aches) 01/2022 - 01/2019
3	Corneal Neovascularization 01/2022 - 01/2014
3	Adenocarcinoma 06/2021 - 11/2012
3	Carcinogenesis 01/2021 - 01/2016
3	Toxoplasmosis 09/2020 - 02/2016
3	Angina Pectoris 04/2020 - 01/2007
3	Heart Failure 01/2020 - 01/2008
3	Renal Cell Carcinoma (Grawitz Tumor) 06/2019 - 08/2016
3	Giant Cell Tumor of Bone 02/2019 - 02/2018
3	Coronary Disease (Coronary Heart Disease) 01/2019 - 12/2009
3	Vesicular Stomatitis 01/2019 - 01/2006
3	Breast Neoplasms (Breast Cancer) 01/2013 - 07/2009
2	Body Weight (Weight, Body) 01/2022 - 02/2015
2	Osteoporosis 01/2022 - 06/2019
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2016
2	Hepatitis 01/2021 - 06/2016
2	Ocular Hypertension (Glaucoma, Suspect) 11/2020 - 08/2018

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2005
9	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2010
8	LipidsIBA 10/2022 - 05/2006
8	omega-Chloroacetophenone (Mace)IBA 04/2020 - 01/2007
6	MicroRNAs (MicroRNA)IBA 01/2022 - 07/2016
6	Pharmaceutical PreparationsIBA 01/2021 - 07/2011
6	Biological ProductsIBA 06/2020 - 01/2013
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2022 - 02/2012
5	Retinaldehyde (Retinal)IBA 01/2022 - 01/2016
5	Messenger RNA (mRNA)IBA 06/2018 - 03/2009
4	VaccinesIBA 01/2022 - 02/2016
4	LuciferasesIBA 07/2021 - 07/2016
4	C-Reactive ProteinIBA 01/2021 - 01/2011
4	Fluorouracil (Carac)FDA LinkGeneric 11/2020 - 04/2005
4	Glycoproteins (Glycoprotein)IBA 01/2019 - 05/2008
4	SaltsIBA 01/2016 - 01/2013
4	Capsules (Microcapsules)IBA 02/2014 - 04/2011
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
3	AlkaliesIBA 01/2022 - 01/2014
3	Monoclonal AntibodiesIBA 01/2022 - 05/2008
3	Oxygen (Dioxygen)IBA 01/2022 - 06/2019
3	SteroidsIBA 01/2021 - 11/2017
3	Clopidogrel (Plavix)FDA Link 10/2019 - 01/2007
3	Therapeutic UsesIBA 01/2019 - 04/2011
3	Indicators and Reagents (Reagents)IBA 01/2018 - 04/2005
3	CXCR ReceptorsIBA 01/2018 - 12/2014
3	Sp1 Transcription FactorIBA 08/2012 - 04/2005
3	Sirolimus (Rapamycin)FDA Link 11/2011 - 01/2007
2	Ethanol (Ethyl Alcohol)IBA 08/2022 - 08/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 02/2015
2	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2021
2	N-acetyltryptophanamide (NATA)IBA 01/2022 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 02/2015
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2021 - 01/2019
2	Adenosine (Adenocard)FDA LinkGeneric 08/2021 - 02/2008
2	AntigensIBA 06/2021 - 09/2020
2	human ERBB2 proteinIBA 01/2021 - 01/2018
2	MetalsIBA 01/2021 - 03/2006
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 02/2019
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2020 - 01/2020
2	Docetaxel (Taxotere)FDA Link 11/2020 - 01/2020
2	Leucovorin (Folinic Acid)FDA Link 11/2020 - 01/2020

Therapy/Procedure

23	Therapeutics 01/2022 - 02/2005
21	Percutaneous Coronary Intervention 01/2021 - 01/2008
10	Stents 01/2021 - 03/2006
10	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2021 - 01/2015
7	Drug-Eluting Stents 01/2019 - 01/2015
6	Neoadjuvant Therapy 02/2022 - 01/2013
5	Drug Therapy (Chemotherapy) 01/2022 - 04/2015
3	Lasers (Laser) 08/2022 - 04/2011
3	Aftercare (After-Treatment) 01/2022 - 01/2019
3	Thrombectomy 01/2020 - 01/2016
3	Adjuvant Chemotherapy 01/2020 - 11/2011
3	Curettage 02/2019 - 02/2018
2	Gastrectomy 01/2021 - 09/2005
2	Catheters 01/2021 - 03/2007